Human Umbilical Cord Mesenchymal Stem Cells Overexpressing RUNX1 Promote Tendon-bone Healing by Inhibiting Osteolysis, Enhancing Osteogenesis and Promoting Angiogenesis

Overview

Journal Genes Genomics

Specialty Genetics

Date 2024 Jan 5

PMID 38180714

Authors

Dan Guo

Jian Yang

Dianwei Liu

Pei Zhang

Hao Sun

Jingcheng Wang

Affiliations

Soon will be listed here.

Abstract

Background: Rotator cuff injury (RCI) is a common shoulder injury, which is difficult to be completely repaired by surgery. Hence, new strategies are needed to promote the healing of tendon-bone.

Objective: We aimed to investigate the effect of human umbilical cord mesenchymal stem cells (hUC-MSCs) overexpressing RUNX1 on the tendon-bone healing after RCI, and to further explore its mechanism.

Methods: Lentiviral vector was used to mediate the overexpression of RUNX1. RUNX1-overexpressed UCB-MSCs (referred to as MSC-RUNX1) were co-cultured with osteoclasts, and TRAP staining was performed to observe the formation of osteoclasts. Then MSC-RUNX1 was cultured in osteogenic differentiation medium, Alizarin red staining was conducted to detect osteogenic differentiation. The expression of markers of osteogenesis and osteoclast was detected by RT-qPCR. EA. hy926 cells were co-cultured with MSC-RUNX1. Transwell assay was used to detect the migration, and the expression of angiogenesis related-genes VEGF and TGF-β was detected by RT-qPCR. The rat rotator cuff reconstruction model was established and MSCs were injected at the tendon-bone junction. Biomechanical test and micro-CT scanning were performed, and HE, Masson and Alcian Blue staining were used for histological evaluation of tendon-bone healing. TUNEL and PCNA immunofluorescence (IF) staining were performed to evaluate apoptosis and proliferation at the tendon-bone healing site. The levels of TNF-α, IL-6 and IL-8 in serum were detected by ELISA. The expression of CD31 and Endomucin that related to angiogenesis was detected by IF. Safranin O-fast and TRAP/CD40L immunohistochemical staining were used to assess the levels of osteoclasts and osteoblasts at the tendon-bone healing site.

Results: hUC-MSCs overexpressing RUNX1 inhibited osteoclast formation and promoted osteogenic differentiation. MSC-RUNX1 could promote the migration and tube formation of EA. hy926 cells, and up-regulate the levels of VEGF and TGF-β. Model mice treated with MSC-RUNX1 partially restored the biomechanical indexes. Treatment of MSC-RUNX1 obviously increased the bone density, accompanied by the formation of new bone. In vivo experiments showed that MSC-RUNX1 treatment could promote tendon-bone healing and inhibit inflammatory response in rats. MSC-RUNX1 treatment also promoted angiogenesis at the tendon-bone healing site, while inhibiting osteoclast formation and promoting osteogenic differentiation.

Conclusion: hUC-MSCs overexpressing RUNX1 can inhibit the formation of osteoclasts and differentiation of osteoblasts, promote angiogenesis and inhibit inflammation, thereby promoting tendon-bone healing after RCI.

Citing Articles

iPSCs-derived iMSCs prevent osteoporotic bone loss and affect bone metabolites in ovariectomized mice.

Wang W, Wang Y, Bao S, He F, Li G, Yang G J Cell Mol Med. 2024; 28(22):e70200.

PMID: 39580790 PMC: 11586054. DOI: 10.1111/jcmm.70200.

[Study on anti-adhesion effect and mechanism of dynamic and static stress stimulation during early healing process of rat Achilles tendon injury].

Wu J, Jiang Y, Wang G, Wang L, Bao J, Wang J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2024; 38(11):1391-1398.

PMID: 39542633 PMC: 11563745. DOI: 10.7507/1002-1892.202405090.

References

Chen H, Yau Y, Ko P, Yen B, Ho C, Hung S . Mesenchymal Stem Cells From a Hypoxic Culture Can Improve Rotator Cuff Tear Repair. Cell Transplant. 2022; 31:9636897221089633. PMC: 9021471. DOI: 10.1177/09636897221089633. View

Dang A, Davies M . Rotator Cuff Disease: Treatment Options and Considerations. Sports Med Arthrosc Rev. 2018; 26(3):129-133. DOI: 10.1097/JSA.0000000000000207. View

Dulak J, Szade K, Szade A, Nowak W, Jozkowicz A . Adult stem cells: hopes and hypes of regenerative medicine. Acta Biochim Pol. 2015; 62(3):329-37. DOI: 10.18388/abp.2015_1023. View

Fitzpatrick L, Atinga A, White L, Henry P, Probyn L . Rotator Cuff Injury and Repair. Semin Musculoskelet Radiol. 2022; 26(5):585-596. DOI: 10.1055/s-0042-1756167. View

Galipeau J, Sensebe L . Mesenchymal Stromal Cells: Clinical Challenges and Therapeutic Opportunities. Cell Stem Cell. 2018; 22(6):824-833. PMC: 6434696. DOI: 10.1016/j.stem.2018.05.004. View

Han L, Fang W, Jin B, Xu S, Zheng X, Hu Y . Enhancement of tendon-bone healing after rotator cuff injuries using combined therapy with mesenchymal stem cells and platelet rich plasma. Eur Rev Med Pharmacol Sci. 2019; 23(20):9075-9084. DOI: 10.26355/eurrev_201910_19310. View

Huang Y, He B, Wang L, Yuan B, Shu H, Zhang F . Bone marrow mesenchymal stem cell-derived exosomes promote rotator cuff tendon-bone healing by promoting angiogenesis and regulating M1 macrophages in rats. Stem Cell Res Ther. 2020; 11(1):496. PMC: 7687785. DOI: 10.1186/s13287-020-02005-x. View

Kang K, Geng Q, Cui L, Wu L, Zhang L, Li T . Upregulation of Runt related transcription factor 1 (RUNX1) contributes to tendon-bone healing after anterior cruciate ligament reconstruction using bone mesenchymal stem cells. J Orthop Surg Res. 2022; 17(1):266. PMC: 9107123. DOI: 10.1186/s13018-022-03152-y. View

Li B, Leung J, Chan L, Yiu W, Tang S . A global perspective on the crosstalk between saturated fatty acids and Toll-like receptor 4 in the etiology of inflammation and insulin resistance. Prog Lipid Res. 2019; 77:101020. DOI: 10.1016/j.plipres.2019.101020. View

10.

Lin K, Wang D, Dines J . Injection Therapies for Rotator Cuff Disease. Orthop Clin North Am. 2018; 49(2):231-239. DOI: 10.1016/j.ocl.2017.11.010. View

11.

Longo U, Rizzello G, Berton A, Maltese L, Fumo C, Khan W . Biological strategies to enhance rotator cuff healing. Curr Stem Cell Res Ther. 2013; 8(6):464-70. DOI: 10.2174/1574888x113086660065. View

12.

Longo U, Carnevale A, Piergentili I, Berton A, Candela V, Schena E . Retear rates after rotator cuff surgery: a systematic review and meta-analysis. BMC Musculoskelet Disord. 2021; 22(1):749. PMC: 8408924. DOI: 10.1186/s12891-021-04634-6. View

13.

Luo Y, Zhang Y, Miao G, Zhang Y, Liu Y, Huang Y . Runx1 regulates osteogenic differentiation of BMSCs by inhibiting adipogenesis through Wnt/β-catenin pathway. Arch Oral Biol. 2018; 97:176-184. DOI: 10.1016/j.archoralbio.2018.10.028. View

14.

Malekpour K, Hazrati A, Zahar M, Markov A, Zekiy A, Gholizadeh Navashenaq J . The Potential Use of Mesenchymal Stem Cells and Their Derived Exosomes for Orthopedic Diseases Treatment. Stem Cell Rev Rep. 2021; 18(3):933-951. PMC: 8224994. DOI: 10.1007/s12015-021-10185-z. View

15.

Omatsu Y, Aiba S, Maeta T, Higaki K, Aoki K, Watanabe H . Runx1 and Runx2 inhibit fibrotic conversion of cellular niches for hematopoietic stem cells. Nat Commun. 2022; 13(1):2654. PMC: 9098511. DOI: 10.1038/s41467-022-30266-y. View

16.

Samsonraj R, Raghunath M, Nurcombe V, Hui J, van Wijnen A, Cool S . Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative Medicine. Stem Cells Transl Med. 2017; 6(12):2173-2185. PMC: 5702523. DOI: 10.1002/sctm.17-0129. View

17.

Song F, Jiang D, Wang T, Wang Y, Chen F, Xu G . Mechanical Loading Improves Tendon-Bone Healing in a Rabbit Anterior Cruciate Ligament Reconstruction Model by Promoting Proliferation and Matrix Formation of Mesenchymal Stem Cells and Tendon Cells. Cell Physiol Biochem. 2017; 41(3):875-889. DOI: 10.1159/000460005. View

18.

Tang J, Xie J, Chen W, Tang C, Wu J, Wang Y . Runt-related transcription factor 1 is required for murine osteoblast differentiation and bone formation. J Biol Chem. 2020; 295(33):11669-11681. PMC: 7450143. DOI: 10.1074/jbc.RA119.007896. View

19.

Uccelli A, Moretta L, Pistoia V . Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2009; 8(9):726-36. DOI: 10.1038/nri2395. View

20.

Um S, Ha J, Choi S, Oh W, Jin H . Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells. World J Stem Cells. 2021; 12(12):1511-1528. PMC: 7789129. DOI: 10.4252/wjsc.v12.i12.1511. View